Linked Data API

Show Search Form

Search Results

1110412
unstar this property registered interest false more like this
star this property date less than 2019-04-08more like thismore than 2019-04-08
star this property answering body
Treasury remove filter
star this property answering dept id 14 more like this
star this property answering dept short name Treasury more like this
star this property answering dept sort name Treasury more like this
star this property hansard heading Research and Development Tax Credit remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Chancellor of the Exchequer, whether he plans to modernise the research and development tax credit to include real-world studies and costs relating to health data to reflect the (a) changing nature of pharmaceutical research and development and (b) ambitions of the UK to be a leader in those areas. more like this
star this property tabling member constituency Bolton West more like this
star this property tabling member printed
Chris Green more like this
star this property uin 242162 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-04-12more like thismore than 2019-04-12
star this property answer text <p>Research and Development (R&amp;D) tax reliefs are an effective and internationally competitive element of the government’s support for innovation. In 2015-16 they provided £3.7 billion worth of relief to innovative businesses and the partial outturn data for 2016-17 shows that this support is on track to rise further. The government keeps all tax reliefs under review.</p><p> </p><p>The government prioritised science and innovation spending at the 2015 Spending Review and since 2016 and has committed an additional £7bn for R&amp;D by 2021-22. This is the largest increase in support for R&amp;D for 40 years and demonstrates progress towards the Industrial Strategy target of increasing economy-wide R&amp;D investment to 2.4% of GDP by 2027.</p><p> </p><p>The UK’s Life Sciences sector is an important part of our economy, contributing over £70 billion a year and 240,000 jobs across the country. The government published two Life Sciences Sector Deals which are supported by commitments to increase R&amp;D investment.</p>
star this property answering member constituency Central Devon more like this
star this property answering member printed Mel Stride more like this
star this property grouped question UIN
242163 more like this
242164 more like this
star this property question first answered
less than 2019-04-12T12:19:07.543Zmore like thismore than 2019-04-12T12:19:07.543Z
star this property answering member
3935
star this property label Biography information for Mel Stride more like this
star this property tabling member
4398
star this property label Biography information for Chris Green remove filter
1110413
unstar this property registered interest false more like this
star this property date less than 2019-04-08more like thismore than 2019-04-08
star this property answering body
Treasury remove filter
star this property answering dept id 14 more like this
star this property answering dept short name Treasury more like this
star this property answering dept sort name Treasury more like this
star this property hansard heading Research and Development Tax Credit remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Chancellor of the Exchequer, whether he plans to modernise the research and development tax credit to include regulatory and other roles integral to pharmaceutical research and development to reflect the multi-disciplinary nature of this work and provide an internationally competitive incentive. more like this
star this property tabling member constituency Bolton West more like this
star this property tabling member printed
Chris Green more like this
star this property uin 242163 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-04-12more like thismore than 2019-04-12
star this property answer text <p>Research and Development (R&amp;D) tax reliefs are an effective and internationally competitive element of the government’s support for innovation. In 2015-16 they provided £3.7 billion worth of relief to innovative businesses and the partial outturn data for 2016-17 shows that this support is on track to rise further. The government keeps all tax reliefs under review.</p><p> </p><p>The government prioritised science and innovation spending at the 2015 Spending Review and since 2016 and has committed an additional £7bn for R&amp;D by 2021-22. This is the largest increase in support for R&amp;D for 40 years and demonstrates progress towards the Industrial Strategy target of increasing economy-wide R&amp;D investment to 2.4% of GDP by 2027.</p><p> </p><p>The UK’s Life Sciences sector is an important part of our economy, contributing over £70 billion a year and 240,000 jobs across the country. The government published two Life Sciences Sector Deals which are supported by commitments to increase R&amp;D investment.</p>
star this property answering member constituency Central Devon more like this
star this property answering member printed Mel Stride more like this
star this property grouped question UIN
242162 more like this
242164 more like this
star this property question first answered
less than 2019-04-12T12:19:07.59Zmore like thismore than 2019-04-12T12:19:07.59Z
star this property answering member
3935
star this property label Biography information for Mel Stride more like this
star this property tabling member
4398
star this property label Biography information for Chris Green remove filter
1110414
unstar this property registered interest false more like this
star this property date less than 2019-04-08more like thismore than 2019-04-08
star this property answering body
Treasury remove filter
star this property answering dept id 14 more like this
star this property answering dept short name Treasury more like this
star this property answering dept sort name Treasury more like this
star this property hansard heading Research and Development Tax Credit remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Chancellor of the Exchequer, whether he plans to change the research and development tax credit to include (a) data processing, (b) clinical trial management and (c) other activity that is subcontracted to third party suppliers in order to match the small medium enterprise research and development tax credit scheme. more like this
star this property tabling member constituency Bolton West more like this
star this property tabling member printed
Chris Green more like this
star this property uin 242164 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-04-12more like thismore than 2019-04-12
star this property answer text <p>Research and Development (R&amp;D) tax reliefs are an effective and internationally competitive element of the government’s support for innovation. In 2015-16 they provided £3.7 billion worth of relief to innovative businesses and the partial outturn data for 2016-17 shows that this support is on track to rise further. The government keeps all tax reliefs under review.</p><p> </p><p>The government prioritised science and innovation spending at the 2015 Spending Review and since 2016 and has committed an additional £7bn for R&amp;D by 2021-22. This is the largest increase in support for R&amp;D for 40 years and demonstrates progress towards the Industrial Strategy target of increasing economy-wide R&amp;D investment to 2.4% of GDP by 2027.</p><p> </p><p>The UK’s Life Sciences sector is an important part of our economy, contributing over £70 billion a year and 240,000 jobs across the country. The government published two Life Sciences Sector Deals which are supported by commitments to increase R&amp;D investment.</p>
star this property answering member constituency Central Devon more like this
star this property answering member printed Mel Stride more like this
star this property grouped question UIN
242162 more like this
242163 more like this
star this property question first answered
less than 2019-04-12T12:19:07.647Zmore like thismore than 2019-04-12T12:19:07.647Z
star this property answering member
3935
star this property label Biography information for Mel Stride more like this
star this property tabling member
4398
star this property label Biography information for Chris Green remove filter